MedTrace Logo

Risk Behaviors in Adolescents With Chronic Diseases

NCT05793411 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-03-31

No results posted yet for this study

Summary

Little is known about the prevalence of risk behaviors (RBs), in adolescents living with a chronic condition (CC) Objectives Main objective: To characterize the engagement of adolescents with somatic CC recognized as ALD (SCC-ALD) into RBs, compared to the French GP Secondary objectives

* To identify factors associated with RBs in adolescents with somatic CC-ALD
* To elicit strategies of preventive action of RBs in adolescents with somatic CC-ALD Methods multicenter, cross-sectional survey , based on a mixed qualitative-quantitative approach with an explanatory sequential design (2 consecutive steps): STEP 1 : QUANTITATIVE COMPONENT

* N expected =500
* Inclusion criteria : 14 to 18 years, With a SCC-ALD,Without cognitive impairment and/or psychiatric disease
* Pseudonymised self-administered paper questionnaire (50 items) completed by eligible adolescents during a visit at referring hospital
* statistical analysis : Comparative to the French GP: matching with two datasets (Enclass-HBSC 2022 and Portraits d'Adolescents 2013 surveys); identification of risk factors and risk subgroups STEP 2 : QUALITATIVE COMPONENT: Focus groups of adolescents with somatic CC-ALD (5 focus groups of 6-8 adolescents, conducted by a researcher in SHS) Perspectives

CARMAC will :

* Provide a better understanding of RBs in adolescents with severe somatic CC and
* Help develop strategies to prevent RBs to enhance the strategies of reducing the addictions to psychoactive substances and health inequalities in this population
* Serve as a methodological model for future studies

Conditions

Interventions

OTHER

Questionnaire risk behaviors in adolescents with chronic diseases

Questionnaire risk behaviors in adolescents with chronic diseases

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Helene MELLERIO, MD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-07-01
Completion
2023-12-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05793411 on ClinicalTrials.gov